Melatonin MT1/MT2 receptor + 5-HT2C receptor

Class

Melatonergic agonist/5-HT2C antagonist

This mechanism combines two receptor actions in a single molecule: agonism at melatonin MT1 and MT2 receptors, and antagonism at the serotonin 5-HT2C receptor. MT1 and MT2 are cell-surface receptors concentrated in the brain's master circadian clock, the suprachiasmatic nucleus, where they respond to the hormone melatonin to align the body's internal rhythm with the external light-dark cycle. Activating these receptors can help resynchronize disrupted sleep-wake timing, a feature seen in mood and sleep disorders. The 5-HT2C receptor, by contrast, is a serotonin receptor that normally exerts an inhibitory influence on the release of other brain chemical messengers, including norepinephrine and dopamine, in areas of the brain governing mood and motivation. Blocking it removes that inhibitory influence, increasing the availability of these messengers in relevant circuits. Pairing melatonergic agonism with 5-HT2C antagonism in one agent is intended to address both the circadian disturbance and the monoaminergic deficits often present in major depressive disorder and related conditions, while avoiding some of the side effects associated with drugs that act directly on serotonin reuptake. This dual mechanism broadly matters in psychiatry and sleep medicine, where circadian misalignment and mood symptoms frequently coexist.